Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Shares Issued (2020 - 2025)

RxSight (RXST) has disclosed Shares Issued for 5 consecutive years, with -$2.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 96.68% year-over-year to -$2.9 million, compared with a TTM value of -$84.4 million through Sep 2025, down 232.85%, and an annual FY2024 reading of $20.8 million, up 119.74% over the prior year.
  • Shares Issued was -$2.9 million for Q4 2025 at RxSight, down from $2.9 million in the prior quarter.
  • Across five years, Shares Issued topped out at $94.1 million in Q3 2024 and bottomed at -$87.3 million in Q4 2024.
  • Average Shares Issued over 4 years is $2.0 million, with a median of $728500.0 recorded in 2023.
  • The sharpest move saw Shares Issued soared 1234.17% in 2024, then crashed 118.12% in 2025.
  • Year by year, Shares Issued stood at $176000.0 in 2021, then crashed by 25427.84% to -$44.6 million in 2023, then plummeted by 95.81% to -$87.3 million in 2024, then soared by 96.68% to -$2.9 million in 2025.
  • Business Quant data shows Shares Issued for RXST at -$2.9 million in Q4 2025, $2.9 million in Q3 2025, and -$696000.0 in Q2 2025.